REG - Dr. Martens PLC - Company Secretary Change

Dr MartensAnnouncement

03/06/2024 09:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240603:nRSC6934Qa&default-theme=true

RNS Number : 6934Q  Dr. Martens PLC  03 June 2024

 

3 June 2024

Dr. Martens plc

 

Company Secretary Appointment

 

Dr. Martens plc (the "Company") announces that Katherine Bellau has been
appointed as Company Secretary with effect from today, 3 June 2024. Katherine
succeeds Emily Reichwald, who will be taking up a different role within the
business.

 

 

 

Enquiries

Investors and analysts
 

Bethany Barnes, Director of Investor Relations
Bethany.Barnes@drmartens.com                     +44 7825 187465

Beth Callum, Investor Relations Manager
                Beth.Callum@drmartens.com
                +44 203 995 2644

 

Press
 

H/Advisors Maitland
 
                                             +44 207
379 5151

Katharine Spence
 
                                                +44
7384 535739

 

Gill Hammond, Director of Communications
 
                                +44 7384 214248

 

 

 

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire.
Produced originally for workers looking for tough, durable boots, the brand
was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens has since transcended its working-class roots while
still celebrating its proud heritage and, six decades later, "Docs" or "DM's"
are worn by people around the world who use them as a symbol of empowerment
and their own individual attitude. The Company is a constituent of the FTSE
250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  COSEAFSFDSSLEFA